Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples